AI assistant
Sending…
SYNOPSYS INC — Director's Dealing 2013
Dec 19, 2013
29855_dirs_2013-12-19_c0e81ab3-39b1-48db-b476-e957384cd220.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2013-12-18
Reporting Person: BEATTIE BRIAN M (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-18 | Common Stock | M | 5000.0 | $17.64 | Acquired | 29166 | Direct |
| 2013-12-18 | Common Stock | S | 5000.0 | $39.0162 | Disposed | 24166 | Direct |
| 2013-12-18 | Common Stock | M | 28000.0 | $21.02 | Acquired | 52166 | Direct |
| 2013-12-18 | Common Stock | S | 28000.0 | $39.0162 | Disposed | 24166 | Direct |
| 2013-12-18 | Common Stock | S | 3545.0 | $39.0162 | Disposed | 20621 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-12-18 | Non-Qualified Stock Option (right to buy) | $17.64 | M | 5000.0 | Disposed | 2015-12-10 | Common Stock (5000) | Direct |
| 2013-12-18 | Non-Qualified Stock Option (right to buy) | $21.02 | M | 28000.0 | Disposed | 2016-12-04 | Common Stock (28000) | Direct |
Footnotes
F1: All shares sold on this date sold at the average price of $39.0162 which consists of: 18642 @ $39.00, 4499 @ $39.01, 4035 @ $39.02, 100 @ $39.0202, 100 @ $39.025, 1740 @ $39.03, 119 @ $39.035, 2300 @ $39.04, 1881 @ $39.05, 1529 @ $39.06, 700 @ $39.07, 100 @ $39.075, 200 @ $39.08, 600 @ $39.09.
F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
More from SYNOPSYS INC
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2